Skip to main content
. 2022 Apr 28;13:893137. doi: 10.3389/fimmu.2022.893137

Figure 2.

Figure 2

Intracellular and surface HSP90β, TRAP1 and STIP1 expression in PB- and BM- derived lymphocytes of lymphoma patients. The mean level of intracellular expression of HSP90β (iHSP90β) (A), iTRAP1 (B) and iSTIP1 (C) (as mean fluorescence intensity; MFI) in lymphocytes derived from PB of HL (n=3), NHL (n=3) patients and healthy controls (n=2). The expression of iHSP90β (D), iTRAP1 (E) and iSTIP1 (F) in lymphocytes derived from BM of HL (n=2) and iHSP90β (G), iTRAP1 (H) and iSTIP1 (I) in NHL (n= 3) patients. (J–L) Surface HSP90β and STIP1 expression in B lymphocytes derived from PB and BM samples of lymphoma patients. (J) The expression of sHSP90β and sSTIP1 in B cells derived from PB of HL (n=3), NHL patients (n=3) and healthy controls (n=2). (K) The expression of sHSP90β and sSTIP1 in B cells derived from PB and BM of HL (n=2). (L) The expression of sHSP90β and sSTIP1 in B cells derived from PB and BM of NHL (n=3) patients. Graphs show mean ± SEM. ns, not significant, *p<0.05, **p< 0.01.